M&A Deal Summary

Wesana Health Acquires PsyTech

On July 13, 2021, Wesana Health acquired life science company PsyTech for 21M CAD

Acquisition Highlights
  • This is Wesana Health’s 1st transaction in the Life Science sector.
  • This is Wesana Health’s largest (disclosed) transaction.
  • This is Wesana Health’s 1st transaction in Canada.
  • This is Wesana Health’s 1st transaction in Ontario.

M&A Deal Summary
Date 2021-07-13
Target PsyTech
Sector Life Science
Buyer(s) Wesana Health
Deal Type Add-on Acquisition
Deal Value 21M CAD
Advisor(s) McDonald Hopkins (Legal)

Target

PsyTech

Toronto, Ontario, Canada
PsyTech combines a robust psychedelic therapeutic community with integrative mental healthcare delivery and enabling tools for novel modalities of care. The company is mainstreaming the adoption of psychedelic-assisted therapies through the promotion and delivery of safe and effective therapy, combating stigma, and accelerating innovation. PsyTech is based in Toronto, Ontario.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Wesana Health

Homer Glen, Illinois, United States
Category Company
Sector Life Science
DESCRIPTION

Wesana Health is a life sciences company involved in the development of innovative approaches for better understanding, protecting, and improving neurological health and performance. Through extensive clinical research and academic partnerships, The company is developing evidence-based formulations and protocols, including psilocybin-based therapies, that empower patients to overcome neurological, psychological, and mental health ailments. Wesana Health is headquartered in Homer Glen, Illinois.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal